Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024530 (
malaria
)
44,886
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Phospholipase A2 activity was detected in Plasmodium falciparum-infected human erythrocytes but not in uninfected red cells. The activity was similar both for trophozoite- and schizont-infected cells. Enzyme activity was Ca(2+)-independent and had a broad pH optimum, with a maximum at pH 8. No detectable
phospholipase A1
activity was found either in infected or uninfected erythrocytes. Phospholipase A2 was inhibited by the anti-malarials chloroquine, quinine, and arteether with concentrations that cause 50% inhibition (IC50) of 1.3, 1.0, and 1.8 mM, respectively. The IC50 value for chloroquine is within the range of concentrations found in the food vacuoles of the
malaria
parasite. Inhibition of the plasmodial phospholipase A2 may, therefore, be relevant for the therapeutic action of this drug.
...
PMID:Inhibition of Plasmodium falciparum phospholipase A2 by chloroquine, quinine, and arteether. 833 77